Logo Img
Logo Img Logo Img
  • Home
    • Platform
    • Services
    • Brands
    • Locations
    • Careers
    • News
    • Library
    • Responsibility
    • Contact Us
  • Platform
    • Our Platform
    • Our Competitive Edge
  • Services
    • Preclinical Development
    • Clinical Development
    • Regulatory Affairs & Consulting
    • Data Sciences
    • Molecular Laboratory R&D Services
    • Microbiology and Diagnostics R&D Services
  • Brands
    • Clinglobal
      • About us
      • Our Services
      • Our Team
    • Clinvet
      • About us
      • Our Services
      • Our Team
    • Clindata
      • About us
      • Our Services
      • Our Team
    • Clinomics
      • About us
      • Our Services
      • Our Team
    • Clinaxel
    • Rtilab
  • Locations
  • Careers
  • News
    • Social Media
  • Library
    • Research Models
    • Publications
  • Responsibility
    • Our Purpose
    • Our Values
    • Corporate Responsibility
    • Compliance
  • Contact us

[contact-form-7 id=”aa96f92″ title=”Themeht-Menu-Form”]

+123 456 789

[email protected]

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution

  1. Home
  2. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution
  • digitalplatforms
  • April 24, 2025
  • 0 Comments
File Type: pdf
File Size: 301 KB
Categories: Publications

Post navigation

Previous
Prevention of Babesia canis in dogs efficacy of a fixed combination of permethrin and fipronil (Effitix(R)) using an experimental transmission blocking model with infected Dermacentor reticulatus ticks
Next
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto)

Search

Categories

  • Clinglobal
  • Uncategorized

Recent News

  • Clinglobal Welcomes Schafer Veterinary Consultants to the Clinaxel Team! Apr 04, 2025
  • Introducing Clinaxel: the new Field Clinical Trials and Regulatory Affairs business unit from Clinglobal Group. Dec 01, 2024
  • Clinglobal Welcomes OCRvet to the Team! Oct 02, 2024
Quick Links
  • About Us
  • Research Models
  • Locations
  • Contact Us
Services
  • Clinical Development
  • Data Sciences
  • Regulatory Affairs & Consulting
  • Molecular Laboratory R&D Services
  • Pre-Clinical Development
  • Microbiology and Diagnostics R&D Services
Compliance
  • PAIA Manual
  • Privacy Notice
Footer Image
Copyright © 2024 All Rights Reserved | Clinglobal | Developed by Digital Platforms